Treatment of CML: thoughts after ASCO 2002.
Talpaz
Moshe
M
University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy / Q000378:metabolism / Q000628:therapy*